Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children
Clinical trial NCT02327936 · COMPLETED
Trial details
- NCT number
- NCT02327936
- Sponsor
- Stéphane Bolduc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-03-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.